Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.0096 | 0.7 |
mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.057 | 0.7 |
mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.7 |
mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.055 | 0.7 |
mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |